Dyne Therapeutics, Inc.
DYN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$108 | -$111 | -$115 | -$90 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $11 | $13 | $0 |
| Change in WC | $6 | $6 | -$4 | -$5 |
| Other Non-Cash | $11 | -$1 | -$0 | $9 |
| Operating Cash Flow | -$91 | -$95 | -$106 | -$84 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$19 | -$0 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$47 | -$41 | -$66 | -$53 |
| Inv. Sales/Matur. | $28 | $48 | $68 | $38 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$38 | $7 | $1 | -$16 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | $99 | $0 | $0 |
| Stock Issued | $218 | $2 | $141 | $4 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $1 | $0 |
| Financing Cash Flow | $217 | $101 | $141 | $4 |
| Forex Effect | -$0 | $0 | $0 | -$0 |
| Net Chg. in Cash | $89 | $13 | $37 | -$97 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $485 | $474 | $437 | $532 |
| End Cash | $574 | $487 | $474 | $435 |
| Free Cash Flow | -$110 | -$95 | -$107 | -$85 |